Cargando…
HCN Channels: New Therapeutic Targets for Pain Treatment
Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are highly regulated proteins which respond to different cellular stimuli. The HCN currents (I(h)) mediated by HCN1 and HCN2 drive the repetitive firing in nociceptive neurons. The role of HCN channels in pain has been widely investi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225464/ https://www.ncbi.nlm.nih.gov/pubmed/30134541 http://dx.doi.org/10.3390/molecules23092094 |
_version_ | 1783369782426337280 |
---|---|
author | Ramírez, David Zúñiga, Rafael Concha, Guierdy Zúñiga, Leandro |
author_facet | Ramírez, David Zúñiga, Rafael Concha, Guierdy Zúñiga, Leandro |
author_sort | Ramírez, David |
collection | PubMed |
description | Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are highly regulated proteins which respond to different cellular stimuli. The HCN currents (I(h)) mediated by HCN1 and HCN2 drive the repetitive firing in nociceptive neurons. The role of HCN channels in pain has been widely investigated as targets for the development of new therapeutic drugs, but the comprehensive design of HCN channel modulators has been restricted due to the lack of crystallographic data. The three-dimensional structure of the human HCN1 channel was recently reported, opening new possibilities for the rational design of highly-selective HCN modulators. In this review, we discuss the structural and functional properties of HCN channels, their pharmacological inhibitors, and the potential strategies for designing new drugs to block the HCN channel function associated with pain perception. |
format | Online Article Text |
id | pubmed-6225464 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62254642018-11-13 HCN Channels: New Therapeutic Targets for Pain Treatment Ramírez, David Zúñiga, Rafael Concha, Guierdy Zúñiga, Leandro Molecules Review Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are highly regulated proteins which respond to different cellular stimuli. The HCN currents (I(h)) mediated by HCN1 and HCN2 drive the repetitive firing in nociceptive neurons. The role of HCN channels in pain has been widely investigated as targets for the development of new therapeutic drugs, but the comprehensive design of HCN channel modulators has been restricted due to the lack of crystallographic data. The three-dimensional structure of the human HCN1 channel was recently reported, opening new possibilities for the rational design of highly-selective HCN modulators. In this review, we discuss the structural and functional properties of HCN channels, their pharmacological inhibitors, and the potential strategies for designing new drugs to block the HCN channel function associated with pain perception. MDPI 2018-08-21 /pmc/articles/PMC6225464/ /pubmed/30134541 http://dx.doi.org/10.3390/molecules23092094 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Ramírez, David Zúñiga, Rafael Concha, Guierdy Zúñiga, Leandro HCN Channels: New Therapeutic Targets for Pain Treatment |
title | HCN Channels: New Therapeutic Targets for Pain Treatment |
title_full | HCN Channels: New Therapeutic Targets for Pain Treatment |
title_fullStr | HCN Channels: New Therapeutic Targets for Pain Treatment |
title_full_unstemmed | HCN Channels: New Therapeutic Targets for Pain Treatment |
title_short | HCN Channels: New Therapeutic Targets for Pain Treatment |
title_sort | hcn channels: new therapeutic targets for pain treatment |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225464/ https://www.ncbi.nlm.nih.gov/pubmed/30134541 http://dx.doi.org/10.3390/molecules23092094 |
work_keys_str_mv | AT ramirezdavid hcnchannelsnewtherapeutictargetsforpaintreatment AT zunigarafael hcnchannelsnewtherapeutictargetsforpaintreatment AT conchaguierdy hcnchannelsnewtherapeutictargetsforpaintreatment AT zunigaleandro hcnchannelsnewtherapeutictargetsforpaintreatment |